However, phenotypic analysis of CD8+ CD20+ T cells revealed an increased percentage of CXCR5+ cells in CLL compared to the control group, and an expansion of CD8+ CD20+ Tc1 cells that was consistent across all patient groups. This evidence concerns the gene CXCR5 and B-cell chronic lymphocytic leukemia.